Literature DB >> 2372338

Nonweightbearing exercise during pregnancy on land and during immersion: a comparative study.

V L Katz1, R McMurray, W E Goodwin, R C Cefalo.   

Abstract

Seven women at 25 weeks' gestation exercised on land and in the water at 70% maximum oxygen capacity (VO2max) on a bicycle ergometer. Women had significantly lower heart rates and lower systolic blood pressures during immersion exercise. Women had a mean diuresis of 207 ml (6.5 ml/min) during water exercise compared with 98 ml. (2.4 ml/min) during land exercise. Fetal heart rates showed a tendency toward being higher after land exercise compared with water exercise. Six of seven fetuses displayed tachycardia after land exercise compared to one of seven after water exercise. Exercise on land and during immersion at 70% VO2max was well tolerated. However, exercise during immersion offers several physiologic advantages during pregnancy.

Entities:  

Mesh:

Year:  1990        PMID: 2372338     DOI: 10.1055/s-2007-999502

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  4 in total

Review 1.  Thermoregulation in pregnancy. Implications for exercise.

Authors:  R G McMurray; V L Katz
Journal:  Sports Med       Date:  1990-09       Impact factor: 11.136

2.  Fetal cardiotocography before and after water aerobics during pregnancy.

Authors:  Carla Silveira; Belmiro G Pereira; Jose G Cecatti; Sergio R Cavalcante; Rosa I Pereira
Journal:  Reprod Health       Date:  2010-08-31       Impact factor: 3.223

3.  Aquatic cycling-What do we know? A scoping review on head-out aquatic cycling.

Authors:  Stefanie Rewald; Ilse Mesters; Antoine F Lenssen; Jens Bansi; Johan Lambeck; Rob A de Bie; Benjamin Waller
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

4.  Water aerobics II: maternal body composition and perinatal outcomes after a program for low risk pregnant women.

Authors:  Sergio R Cavalcante; Jose G Cecatti; Rosa I Pereira; Erica P Baciuk; Ana L Bernardo; Carla Silveira
Journal:  Reprod Health       Date:  2009-01-06       Impact factor: 3.223

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.